找回密码
 To register

QQ登录

只需一步,快速开始

扫一扫,访问微社区

SCIE期刊Therapeutic Advances in Medical Oncology 2024/2025影响因子:4.323 (THER ADV MED ONCOL) (1758-8340). (ONCOLOGY)(肿瘤学)Sci

[复制链接]
楼主: GUST
发表于 2025-3-23 10:48:29 | 显示全部楼层
发表于 2025-3-23 15:37:10 | 显示全部楼层
Submitted on: 18 August 2003. Revised on: 24 September 2003. Accepted on: 12 October 2003. Therapeutic Advances in Medical Oncology
发表于 2025-3-23 18:35:34 | 显示全部楼层
Submitted on: 01 January 2018. Revised on: 31 January 2018. Accepted on: 10 February 2018. Therapeutic Advances in Medical Oncology
发表于 2025-3-23 22:30:36 | 显示全部楼层
Submitted on: 26 December 2012. Revised on: 31 January 2013. Accepted on: 15 February 2013. Therapeutic Advances in Medical Oncology
发表于 2025-3-24 04:49:12 | 显示全部楼层
Submitted on: 05 August 2017. Revised on: 19 August 2017. Accepted on: 08 September 2017. Therapeutic Advances in Medical Oncology
发表于 2025-3-24 08:10:14 | 显示全部楼层
发表于 2025-3-24 12:41:14 | 显示全部楼层
发表于 2025-3-24 17:11:24 | 显示全部楼层
发表于 2025-3-24 20:30:00 | 显示全部楼层
Submitted on: 21 December 2023. Revised on: 29 December 2023. Accepted on: 25 January 2024. Therapeutic Advances in Medical Oncology
发表于 2025-3-24 23:11:00 | 显示全部楼层
 关于派博传思  派博传思旗下网站  友情链接
派博传思介绍 公司地理位置 论文服务流程 影响因子官网 SITEMAP 大讲堂 北京大学 Oxford Uni. Harvard Uni.
发展历史沿革 期刊点评 投稿经验总结 SCIENCEGARD IMPACTFACTOR 派博系数 清华大学 Yale Uni. Stanford Uni.
|Archiver|手机版|小黑屋| 派博传思国际 ( 京公网安备110108008328) GMT+8, 2025-4-27 10:01
Copyright © 2001-2015 派博传思   京公网安备110108008328 版权所有 All rights reserved
快速回复 返回顶部 返回列表